Tularaemia - An overview of the current knowledge;Tularémie - Přehled současných poznatků

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 16, Issue 1, 2010, Pages 22-27

  Lukasova E ^a   Cermak P ^b,c   Smela G ^a,b   Jedlickova A ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

Author keywords

Clinical picture; Epidemiology; Francisella tularensis; Therapy; Tularaemia

Indexed keywords

WATER;

AEROSOL; EPIDEMIC; FOOD; FRANCISELLA TULARENSIS; FRANCISELLACEAE; GEOGRAPHIC DISTRIBUTION; HUMAN; NONHUMAN; PATHOGENICITY; REVIEW; SUBSPECIES; TULAREMIA; VIRUS TRANSMISSION; ZOONOSIS; DISEASE TRANSMISSION; PATHOLOGY;

HUMANS; TULAREMIA;

EID: 77951613890     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Keim P, Johansson A, Wagner DM. Molecular epidemiology, evolution and ekology of Francisella. Ann N Y Acad Sci. 2007;1105:30-66.
2. Molins-Schneekloth CR, Belidle JT, Petersen JM. Genomic, Markers for differentiation of Francisella tularensis subsp. tularensis A.I and A.II strains. Appl Environ Microbiol 2008 January;74(1):336-341
3. Griffin KF, Oyston PC, Titball RW et al. Francisella tularensis vaccines. FEMS Immunol Med Microbiol. 2007;49(3):315-323
4. Čenrý Z. Tularémie na jižní Moravě opět aktivnější. Klin Microbiol Inf Lek 2000;6(3):66-72.
5. Alue M, Ruiz Sopeña C, Gallardo M et al. Tularemia outbreak in Castilla y León, Spain 2007. Euro Surveill. 2008;13(32): 18948.
6. Kaysser P, Seibold E et al. Re-emergence of tularemia in Germany: Presence of Francisella tularensis in different rodent species in endemic areas. BMC Infect Dis. 2008;8:157.
7. Libich J. Tularémie 1. vyd. Praha: Avicenum; 1981.
8. Páv J a kol. Choroby lovné zvěře. 1. vyd. Praha: Státní zemédělské nakladatelství; 1981.
9. Petersen JM et al. Francisella tularensis: an arthropod-borne pathogen. Vet Res. 2009;40(2):7.
10. Hubálek Z, Rudolf I. Mikrobiální zoonózy a sapronózy. 2. vyd. Brno: Masarykova univerzita; 2007.
11. Pazdiora P, Beneš Č. Změny ve výskytu tularémie v Západočeském kraji a v ČR, možnosti vakcinace. Hradecké vakcinologické dny 18.-20.9.2008; www.pmfhk.cz/Prednasky/VAKCI08/25,2008
12. Haeys EB. Tick-Borne Disease of Humans. Washington, DC: ASM Press; 2005. s. 207-217
13. Lobovskǎ A, Havlíčková I, Aster V. Tularémie- stále aktuální zoonóza. Klin Microbiol Inf Lek. 2000;6(3):73-76
14. Infekce v ČR - EPIDAT. Avaiable from: httpy/www.szu.cz/infekce/, 2008.
15. Kirimanjeswara G, Osmos S, Bakshi CS, Metzger DW. Mucosal and cell -mediated immunity to me intracellular pathogen Francisella tularensis. Immunol Rev. 2008;225:244-1225
16. Metzger DW, Bakshi CS, Kirimanjeswara G. Mucosal imunopathogenesis of Francisella tularensis. Ann N Y Acad Sci. 2007;1105:266-283.
17. Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM. Initial deal in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Imun. 2008;76(7):3001-3010.
18. Oyston PC. Francisella tularensis: unravelling the secrets of anintracellular pathogen. J Med Microbiol. 2008;57(8):921-930
19. Havlík J a kol. Infektologie. 1. vyd. Praha: Avicenum; 1990; s.161-2.
20. Bystrom M, Böcher S et al. Tularemia in Denmark: Identification of a Francisella tularensis subsp. holarctica strain by real-Time PCR and high-resolution typing by multiple-locus variable-number tandem repeat analysis. J Clin Microbiol. 2005;43(10):5355-5358 (Pubitemid 41484059)
21. Splettstoesser WD et al. Diagnostic procedures in tularaemia with special focus on molecular and immunological techniques. J Vet Med B Infect Dis Vet Public Health. 2005;52(6):249-261
22. Votava M. Kultivační pu̇dy v lékař ské mikrobiologii. 1. vyd. Brno: Neptun; 2001.
23. Petersen M et al. Methods for enhanced culture recovery of Francisella tularensis. Appl Environ Microbiol. 2004;70(6):3733-3735
24. Támvik A, Chu MC. New approaches to diagnosisand therapy of tularemia. Ann N Y Acad Sci. 2007;1105:378-404. (Pubitemid 47507098)
25. Brouqui P et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 2004;10(12):1108-1132 (Pubitemid 40050854)
26. Tannic A, Henning C et al. Isolation of Franciselia tularensis biovar palaearctica from human blood. Eur J Clin Microbiol Dis. 1989;8(2): 146-150 (Pubitemid 19072647)
27. Dennis DT, Inglesby TV, Henderson DA et al. Tularemia as a biological weapon: medical and public healdi management JAMA. 2001;(285)21:2763-2773
28. Patočka F a spol. Lékařská mikrobiologie. 1. vyd. Praha: Avicenum; 1972. s. 429-434.
29. Rozsypal S. Obecná bakteriologie. 1. vyd. Praha: SPN; 1981. s. 646.
30. Fabiánová K, Čásucová J. Opatření při výskytu tularémie v ČR, 4/2008. Avaible from: http://www.szu.cz/tema/prevence/opatreni-pri-vyskytu- tularemie-v-cr-1, 2008
31. Presence of low levels of Francisella tularensis in the Washington DC. area, September 30, 2005. Office of Communicable Diseases Information for Health Care Providers,Alerts, Advisories, Updates, CDC Healdi Advisory, htp://www.health.state.ri.us/disease/communicable/providers-tularemia-dc.php. 2008.
32. http://www.bioveta.cz, 2008
33. httpy/www.virion-serion.de:80,2008
34. Gilbert D, Moellering R, Eliopoulos G et al. The Sandford guide to antimicrobial therapy. 39. Edition, Sperryville: 2009; s. 55,63.
35. Vacek V, Hejzlar M et al. Chemoterapie infekčních nemocí v klinické praxi. 1. vyd. Praha: Avicenum; 1988. s. 285.
36. Centers for Disease Control and Prevention,1600 Clifton Rd. Atlanta, GA 30333, USA http://www.bt.cdc.gov/agent/tularemia/index.asp, 2008
37. Beneš J. Léčha tularémie v závislosti na formě a stadiu nemoci. Klin Microbiol Inf Lek. 2003;6(3):79-83.
38. Urich SK, Petersen JM. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob Agents Chemother. 2008 June; 52(6):2276-2278
39. Rawcol DB, Bitsaktsis C, Gosselin RD et al. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis, J Imunol. 2008;180(8):5548-5557
40. Baron SD, Singh R. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect Immun. 2007;75(5):2152-2162